<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: retinal disease</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Retinopathy severity linked to cardiovascular outcome</title>
   	 <description>(HealthDay)—For individuals with type 2 diabetes, incident cardiovascular outcomes are determined not only by the severity of diabetic retinopathy but also by its progression, according to research published online Dec. 13 in Diabetes Care.</description>
	  <link>http://medicalxpress.com/news/2013-01-retinopathy-severity-linked-cardiovascular-outcome.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 25 Jan 2013 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news278332366</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/retinopathys.jpg" width="90" height="90" />
</item>
<item>
     <title>Inherited retinal disease research may lead to treatment</title>
   	 <description>Inherited retinal disease is a major cause of vision impairment in early life - and a researcher at The University of Western Australia hopes a study in which he was involved will contribute towards the development of a drug-based treatment.</description>
	  <link>http://medicalxpress.com/news/2013-01-inherited-retinal-disease-treatment.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 08 Jan 2013 05:59:10 EST</pubDate>
	 <guid isPermaLink="false">news276847139</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/inheritedret.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA recommends approval for Second Sight's Argus II retinal prosthesis system in the US</title>
   	 <description>On Friday September 28, a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel unanimously voted 19-0 that the probable benefit of the Argus II Retinal Prosthesis System outweighs the risks to health, an important step toward the FDA market approval of this product manufactured by Second Sight Medical Products, Inc. In making this determination, the panel spent ten hours carefully reviewing and discussing data submitted from the international clinical trial of this innovative retinal implant that, for the first time ever, partially restores vision to patients who are blind due to Retinitis Pigmentosa (RP).</description>
	  <link>http://medicalxpress.com/news/2012-10-fda-sight-ii-retinal-prosthesis.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Wed, 03 Oct 2012 04:03:12 EST</pubDate>
	 <guid isPermaLink="false">news268455784</guid>
	 
</item>
<item>
     <title>New advances in treating inherited retinal diseases highlighted in Human Gene Therapy</title>
   	 <description>Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Human Gene Therapy website at http://www.liebertpub.com/hum.</description>
	  <link>http://medicalxpress.com/news/2012-05-advances-inherited-retinal-diseases-highlighted.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 08 May 2012 12:51:42 EST</pubDate>
	 <guid isPermaLink="false">news255700295</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newadvancesi.jpg" width="90" height="90" />
</item>
<item>
     <title>New pig model may lead to progress in treating debilitating eye disease</title>
   	 <description>A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States. The pig model was developed by researchers in the University of Louisville Department of Ophthalmology &amp; Visual Sciences and at the National Swine Resource and Research Center at the University of Missouri.</description>
	  <link>http://medicalxpress.com/news/2012-03-pig-debilitating-eye-disease.html</link>
	 <category>Ophthalmology</category>
	 <pubDate>Thu, 08 Mar 2012 14:54:05 EST</pubDate>
	 <guid isPermaLink="false">news250440710</guid>
	 
</item>
<item>
     <title>Gene therapy for inherited blindness succeeds in patients' other eye</title>
   	 <description>Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred.</description>
	  <link>http://medicalxpress.com/news/2012-02-gene-therapy-inherited-patients-eye.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 08 Feb 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news247919918</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genetherapyf.jpg" width="90" height="90" />
</item>
<item>
     <title>Gene therapy research cures retinitis pigmentosa in dogs</title>
   	 <description>Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs.</description>
	  <link>http://medicalxpress.com/news/2012-01-gene-therapy-retinitis-pigmentosa-dogs.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 23 Jan 2012 15:00:12 EST</pubDate>
	 <guid isPermaLink="false">news246550009</guid>
	 
</item>
<item>
     <title>Ophthalmic antibiotics associated with antimicrobial resistance after intraocular injection therapy</title>
   	 <description>Repeated exposure of the eye to ophthalmic antibiotics appears to be associated with the emergence of resistant strains of microbes among patients undergoing intraocular injection therapy for neovascular retinal disease, according to a report in the September issue of Archives of Ophthalmology.</description>
	  <link>http://medicalxpress.com/news/2011-09-ophthalmic-antibiotics-antimicrobial-resistance-intraocular.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 12 Sep 2011 16:31:06 EST</pubDate>
	 <guid isPermaLink="false">news235063799</guid>
	 
</item>
<item>
     <title>Latest advances in gene therapy for ocular disease are highlighted in Human Gene Therapy</title>
   	 <description>Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body. A series of articles available online ahead of print in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., highlight several exciting developments in ocular gene therapy. The articles are available free online at www.liebertpub.com/hum</description>
	  <link>http://medicalxpress.com/news/2011-05-latest-advances-gene-therapy-ocular.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 09 May 2011 15:53:56 EST</pubDate>
	 <guid isPermaLink="false">news224175194</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/latestadvanc.jpg" width="90" height="90" />
</item>


</channel>
</rss>
